Osteoporosis treatment: Focus on safety

European Journal of Internal Medicine

Volumn 24, Issue 8, 2013, Pages 691-697

  Reid, Ian R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Bisphosphonate; Calcium; Osteoporosis; Vitamin D

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; DENOSUMAB; ESTROGEN; PARATHYROID HORMONE[1-34]; RALOXIFENE; STRONTIUM; VITAMIN D;

ACUTE PHASE RESPONSE; BREAST CANCER; CALCIUM BLOOD LEVEL; CANCER PATIENT; CARDIOVASCULAR DISEASE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIET SUPPLEMENTATION; DISABILITY; DRUG SAFETY; DRUG TOLERABILITY; FALLING; FEMUR SHAFT FRACTURE; FEMUR SUBTROCHANTERIC FRACTURE; FLU LIKE SYNDROME; FRACTURE; FRAGILITY FRACTURE; FRAIL ELDERLY; GASTROINTESTINAL SYMPTOM; HEART INFARCTION; HUMAN; JAW OSTEONECROSIS; MORTALITY; NEPHROLITHIASIS; NONHUMAN; OSTEOPOROSIS; REVIEW; SIDE EFFECT; SKIN MANIFESTATION; VENOUS THROMBOEMBOLISM;

BISPHOSPHONATE; CALCIUM; OSTEOPOROSIS; VITAMIN D;

ACUTE-PHASE REACTION; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BONE DENSITY CONSERVATION AGENTS; CALCIUM; CONSTIPATION; DIPHOSPHONATES; FEMALE; GASTROENTERITIS; HUMANS; KIDNEY CALCULI; MALE; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; VITAMIN D;

EID: 84889639618     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2013.03.012     Document Type: Review

References (71)

1. G. Jones, T. Nguyen, P.N. Sambrook, P.J. Kelly, C. Gilbert, and J.A. Eisman Symptomatic fracture incidence in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES) Osteoporos Int 4 1994 277 282
2. W.S. Browner, A.R. Pressman, M.C. Nevitt, and S.R. Cummings Mortality following fractures in older women - the study of osteoporotic fractures Arch Int Med 156 1996 1521 1525
3. D. Bliuc, N.D. Nguyen, V.E. Milch, T.V. Nguyen, J.A. Eisman, and J.R. Center Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women JAMA 301 2009 513 521
4. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, and M.L. Stefanick Risks and benefits of estrogen plus progestin in healthy postmenopausal women - principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
5. A.B. Grey, J.P. Stapleton, M.C. Evans, M.A. Tatnell, R.W. Ames, and I.R. Reid The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal women Am J Med 99 1995 636 641
6. I.R. Reid, R. Eastell, I. Fogelman, J.D. Adachi, A. Rosen, and C. Netelenbos A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women Arch Int Med 164 2004 871 879
7. B. Ettinger, D.M. Black, B.H. Mitlak, R.K. Knickerbocker, T. Nickelsen, and H.K. Genant Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene - results from a 3-year randomized clinical trial JAMA 282 1999 637 645
8. J.Y. Reginster, E. Seeman, M.C. De Vernejoul, S. Adami, J. Compston, and C. Phenekos Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study J Clin Endocrinol Metab 90 2005 2816 2822
9. M. Le Merlouette, H. Adamski, M. Dinulescu, F. Le Gall, F. Colin, and H. Grimaud Strontium ranelate-induced DRESS syndrome Ann Dermatol Venereol 138 2011 124 128
10. K.W. Tan, Y.S. Wang, and Y.K. Tay Stevens-Johnson syndrome due to strontium ranelate Ann Acad Med Singapore 40 2011 510 511
11. R.M. Neer, C.D. Arnaud, J.R. Zanchetta, R. Prince, G.A. Gaich, and J.Y. Reginster Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis N Engl J Med 344 2001 1434 1441
12. S.R. Cummings, J.S. Martin, M.R. McClung, E.S. Siris, R. Eastell, and I.R. Reid Denosumab for prevention of fractures in postmenopausal women with osteoporosis N Engl J Med 361 2009 756 765
13. P.D. Miller, M.A. Bolognese, E.M. Lewiecki, M.R. McClung, B.Y. Ding, and M. Austin Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial Bone 43 2008 222 229
14. J.A. Eisman, H.G. Bone, D.J. Hosking, M.R. McClung, I.R. Reid, and R. Rizzoli Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect J Bone Miner Res 26 2011 242 251
15. L. Steingrimsdottir, O. Gunnarsson, O.S. Indridason, L. Franzson, and G. Sigurdsson Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake JAMA 294 2005 2336 2341
16. R.P. Heaney, R.R. Recker, and P.D. Saville Calcium balance and calcium requirements in middle-aged women Am J Clin Nutr 30 1977 1603 1611
17. R.P. Heaney, R.R. Recker, and P.D. Saville Menopausal changes in calcium balance performance J Lab Clin Med 92 1978 953 963
18. D.M. Spiegel, and K. Brady Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets Kidney Int 81 2012 1116 1122
19. I.R. Reid, B. Mason, A. Horne, R. Ames, H.E. Reid, and U. Bava Randomized controlled trial of calcium in healthy older women Am J Med 119 2006 777 785
20. B.M.P. Tang, G.D. Eslick, C. Nowson, C. Smith, and A. Bensoussan Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis Lancet 370 2007 657 666
21. J.R. Lewis, K. Zhu, and R.L. Prince Adverse events from calcium supplementation: relationship to errors in myocardial infarction self-reporting in randomized controlled trials of calcium supplementation J Bone Miner Res 27 2012 719 722
22. R.D. Jackson, A.Z. LaCroix, M. Gass, R.B. Wallace, J. Robbins, and C.E. Lewis Calcium plus vitamin D supplementation and the risk of fractures N Engl J Med 354 2006 669 683
23. E. Warensjo, L. Byberg, H. Melhus, R. Gedeborg, H. Mallmin, and A. Wolk Dietary calcium intake and risk of fracture and osteoporosis: prospective longitudinal cohort study BMJ 2011 342
24. R.G. Cumming, S.R. Cummings, M.C. Nevitt, J. Scott, K.E. Ensrud, and T.M. Vogt Calcium intake and fracture risk - results from the study of osteoporotic fractures Am J Epidemiol 145 1997 926 934
25. I.R. Reid, M.J. Bolland, and A. Grey Effect of calcium supplementation on hip fractures Osteoporos Int 19 2008 1119 1123
26. M.J. Bolland, P.A. Barber, R.N. Doughty, B. Mason, A. Horne, and R. Ames Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial BMJ 336 2008 262 266
27. M.J. Bolland, A. Avenell, J.A. Baron, A. Grey, G.S. MacLennan, and G.D. Gamble Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis BMJ 341 2010 C3691
28. J. Hsia, G. Heiss, H. Ren, M. Allison, N.C. Dolan, and P. Greenland Calcium/vitamin D supplementation and cardiovascular events Circulation 115 2007 846 854
29. M.J. Bolland, A. Grey, G.D. Gamble, and I.R. Reid Calcium/vitamin D supplements and health outcomes: a re-analysis of the Women's Health Initiative imited-access dataset Am J Clin Nutr 94 2011 1144 1149
30. I.R. Reid, M.J. Bolland, and A. Grey Does calcium supplementation increase cardiovascular risk? Clin Endocrinol 73 2010 689 695
31. E.V. McCloskey, M. Beneton, D. Charlesworth, K. Kayan, D. Detakats, and A. Dey Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study J Bone Miner Res 22 2007 135 141
32. B. Abrahamsen, T. Masud, A. Avenell, F. Anderson, H.E. Meyer, and C. Cooper Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe BMJ 2010 340
33. M.C. Chapuy, M.E. Arlot, F. Duboeuf, J. Brun, B. Crouzet, and S. Arnaud Vitamin-D3 and calcium to prevent hip fractures in elderly women N Engl J Med 327 1992 1637 1642
34. K.M. Sanders, A.L. Stuart, E.J. Williamson, J.A. Simpson, M.A. Kotowicz, and D. Young Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial JAMA 303 2010 1815 1822
35. D. Durup, H.L. Jørgensen, J. Christensen, P. Schwarz, A.M. Heegaard, and B. Lind A reverse j-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice, the CopD Study J Clin Endocrinol Metab 2012 10.1210/jc.2012-1176
36. I.R. Reid, G.D. Gamble, P. Mesenbrink, P. Lakatos, and D.M. Black Characterization of and risk factors for the acute-phase response after zoledronic acid J Clin Endocrinol Metab 95 2010 4380 4387
37. J.D. Wark, W. Bensen, C. Recknor, O. Ryabitseva, J. Chiodo, and P. Mesenbrink Treatment with acetaminophen/paracetamol or ibuprofen alleviates post-dose symptoms related to intravenous infusion with zoledronic acid 5 mg Osteoporos Int 23 2012 503 512
38. D.M. Black, P.D. Delmas, R. Eastell, I.R. Reid, S. Boonen, and J.A. Cauley Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis N Engl J Med 356 2007 1809 1822
39. K.W. Lyles, C.S. Colon-Emeric, J.S. Magaziner, J.D. Adachi, C.F. Pieper, and C. Mautalen Zoledronic acid and clinical fractures and mortality after hip fracture N Engl J Med 357 2007 1799 1809
40. R. Karam, J. Camm, and M. McClung Yearly zoledronic acid in postmenopausal osteoporosis N Engl J Med 357 2007 712 713
41. S.R. Cummings, A.V. Schwartz, and D.M. Black Alendronate and atrial fibrillation N Engl J Med 356 2007 1895 1896
42. E.M. Lewiecki, C. Cooper, E. Thompson, F. Hartl, D. Mehta, and S.E. Papapoulos Ibandronate does not increase risk of atrial fibrillation in analysis of pivotal clinical trials Int J Clin Pract 64 2010 821 826
43. H.T. Sorensen, S. Christensen, F. Mehnert, L. Pedersen, R.D. Chapurlat, and S.R. Cummings Use of bisphosphonates among women and risk of atrial-fibrillation and flutter: population based case-control study BMJ 336 2008 813 816
44. B. Abrahamsen, P. Eiken, and K. Brixen Atrial fibrillation in fracture patients treated with oral bisphosphonates J Intern Med 265 2009 581 592
45. T.J. Bunch, J.L. Anderson, H.T. May, J.B. Muhlestein, B.D. Home, and B.G. Crandall Relation of bisphosphonate therapies and risk of developing atrial fibrillation Am J Cardiol 103 2009 824 828
46. H. Khalili, E.S. Huang, S. Ogino, C.S. Fuchs, and A.T. Chan A prospective study of bisphosphonate use and risk of colorectal cancer J Clin Oncol 30 2012 3229 3233
47. B. Abrahamsen, M. Pazianas, P. Eiken, R.G.G. Russell, and R. Eastell Esophageal and gastric cancer incidence and mortality in alendronate users J Bone Miner Res 27 2012 679 686
48. E.B.K. Kwek, S.K. Goh, J.S.B. Koh, M.A. Png, and Howe T. Sen An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury 39 2008 224 231
49. B.A. Lenart, D.G. Lorich, and J.M. Lane Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate N Engl J Med 358 2008 1304 1306
50. F. Feldman Atypical diaphyseal femoral fractures - new aspects Skeletal Radiol 41 2012 75 81
51. L.Y. Park-Wyllie, M.M. Mamdani, D.N. Juurlink, G.A. Hawker, N. Gunraj, and P.C. Austin Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women JAMA 305 2011 783 789
52. D.M. Black, M.P. Kelly, H.K. Genant, L. Palermo, R. Eastell, and C. Bucci-Rechtweg Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur N Engl J Med 362 2010 1761 1771
53. J.W. Nieves, J.P. Bilezikian, J.M. Lane, T.A. Einhorn, Y. Wang, and M. Steinbuch Fragility fractures of the hip and femur: incidence and patient characteristics Osteoporos Int 21 2010 399 408
54. B. Abrahamsen, P. Eiken, and R. Eastell Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study J Bone Miner Res 24 2009 1095 1102
55. B. Abrahamsen, P. Eiken, R.A.F.N.A.B. Eastell, P. Eiken, and R. Eastell Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis J Clin Endocrinol Metab 95 2010 5258 5265
56. J. Schilcher, K. Michaelsson, and P. Aspenberg Bisphosphonate use and atypical fractures of the femoral shaft N Engl J Med 364 2011 1728 1737
57. R.P.H. Meier, T.V. Perneger, R. Stern, R. Rizzoli, and R.E. Peter Increasing occurrence of atypical femoral fractures associated with bisphosphonate use Arch Int Med 172 2012 930 936
58. R.M. Dell, A.L. Adams, D.F. Greene, T.T. Funahashi, S.L. Silverman, and E.O. Eisemon Incidence of atypical nontraumatic diaphyseal fractures of the femur J Bone Miner Res 27 2012 2544 2550
59. I. Reid, and J. Cornish Epidemiology and pathogenesis of osteonecrosis of the jaw Nat Rev Rheumatol 8 2012 90 96
60. V.M. Cartsos, S. Zhu, and A.I. Zavras Bisphosphonate use and the risk of adverse jaw outcomes J Am Dent Assoc 139 2008 23 30
61. M. Pazianas, W.A. Blumentals, and P.D. Miller Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker Osteoporos Int 19 2008 773 779
62. W.S. Browner, D.G. Seeley, T.M. Vogt, and S.R. Cummings Non-trauma mortality in elderly women with low bone mineral density Lancet 338 1991 355 358
63. C.S. Colon-Emeric, P. Mesenbrink, K.W. Lyles, C.F. Pieper, S. Boonen, and P. Delmas Potential mediators of the mortality reduction with zoledronic acid after hip fracture J Bone Miner Res 25 2010 91 97
64. M.J. Bolland, A.B. Grey, G.D. Gamble, and I.R. Reid Effect of osteoporosis treatment on mortality: a meta-analysis J Clin Endocrinol Metab 95 2010 1174 1181
65. Wolfe F, Bolster MB, O'Connor CM, Michaud K, Lyles KW, Colón-Emeric CS. Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis. J Bone Min Res. in press.
66. U. Laufs, and J.K. Liao Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase J Biol Chem 273 1998 24266 24271
67. J.R. Center, D. Bliuc, N.D. Nguyen, T.V. Nguyen, and J.A. Eisman Osteoporosis medication and reduced mortality risk in elderly women and men J Clin Endocrinol Metab 96 2011 1006 1014
68. Schwartz AV, Schafer AL, Grey A, Vittinghoff E, Palermo L, Lui L-YL, et al. Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT and FREEDOM trials. J Bone Min Res. in press.
69. J.M. Lappe, D. Travers-Gustafson, K.M. Davies, R.R. Recker, and R.P. Heaney Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial Am J Clin Nutr 85 2007 1586 1591
70. A.M. Grant, A. Avenell, M.K. Campbell, A.M. McDonald, G.S. MacLennan, and G.C. McPherson Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial Lancet 365 2005 1621 1628
71. M.J. Bolland, A. Grey, A. Avenell, G.D. Gamble, and I.R. Reid Calcium/vitamin D supplements and cardiovascular events: a re-analysis of the Women's Health Initiative limited-access dataset, and meta-analysis of calcium with or without vitamin D BMJ 342 2011 d2040 10.1136/bmj.d2040